Istituto Giannina Gaslini
Clinical trials sponsored by Istituto Giannina Gaslini, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a probiotic soothe fibromyalgia pain in young people? Results expected Sep 2026 (estimated)
- New study aims to find best painkiller for C-Section recovery Results expected Mar 2027 (estimated)
- New iron supplement could help celiac kids recover faster Results expected Mar 2027 (estimated)
- Zapping the brain to fight teen pain: a new hope? Results expected Mar 2027 (estimated)
- New app aims to empower young cancer survivors Results expected Jun 2027 (estimated)
-
Could a probiotic soothe fibromyalgia pain in young people?
Disease control Not yet recruitingThis study tests whether a daily probiotic supplement, Bifidobacterium adolescentis PRL2019, can reduce pain in young people aged 9 to 25 with juvenile fibromyalgia, a condition marked by widespread musculoskeletal pain. Participants will take the probiotic or a placebo for 12 we…
Sponsor: Istituto Giannina Gaslini • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New app aims to empower young cancer survivors
Symptom relief Not yet recruitingThis study tests a web app called MyCare eQuoL that helps childhood cancer survivors assess their needs and get personalized support. About 200 survivors aged 16-30 from nine European countries will use the app for six months. The goal is to see if the app helps them feel more in…
Sponsor: Istituto Giannina Gaslini • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New study aims to find best painkiller for C-Section recovery
Symptom relief Not yet recruitingThis study compares two ways to manage pain after a planned C-section: a small dose of morphine given with the spinal anesthesia, versus a nerve block (TAP block) using numbing medicine. One hundred women will be randomly assigned to one of the two groups. The goal is to see whic…
Phase 4 • Sponsor: Istituto Giannina Gaslini • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can Drug-Level testing personalize cystic fibrosis treatment?
Knowledge-focused Not yet recruitingResearchers are studying how the cystic fibrosis drugs elexacaftor, tezacaftor and ivacaftor move through the body. The trial enrolls people aged 6 and older with cystic fibrosis who carry at least one F508del mutation and already take this drug combination. Participants keep the…
Phase 4 • Sponsor: Istituto Giannina Gaslini • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC